Cargando…
Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
Global people are suffering from the legion of diseases. Cytotoxic property of the chemical compound would not solely influence effective drug properties and reduce unnecessary side effects. Proteins/enzymes responsible for microbe proliferation or survival are specifically targeted and inhibited su...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132078/ https://www.ncbi.nlm.nih.gov/pubmed/32274429 http://dx.doi.org/10.1016/j.heliyon.2020.e03656 |
_version_ | 1783517378452127744 |
---|---|
author | Dorababu, Atukuri |
author_facet | Dorababu, Atukuri |
author_sort | Dorababu, Atukuri |
collection | PubMed |
description | Global people are suffering from the legion of diseases. Cytotoxic property of the chemical compound would not solely influence effective drug properties and reduce unnecessary side effects. Proteins/enzymes responsible for microbe proliferation or survival are specifically targeted and inhibited successfully making the cells to undergo apoptosis. Furthermore, isoforms of essential enzymes have distinct physiological functions; thereby inhibition of essential enzyme isoforms is an apt way to the clinical approach of disease neutralization. Drugs are designed so as to play significant roles such as signaling pathways in the oncogenic process including cell proliferation, invasion, and angiogenesis. The present review comprises collective information of the recent synthesis of various organic drug compounds in brief, which could inhibit particular enzyme. The review also covers the correlation of the structure of a drug molecule designed and its inhibitory activity. Also, the most significant enzyme inhibitors are highlighted and structural moieties/core units responsible for remarkable inhibitory values are emphasized. |
format | Online Article Text |
id | pubmed-7132078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-71320782020-04-09 Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles Dorababu, Atukuri Heliyon Article Global people are suffering from the legion of diseases. Cytotoxic property of the chemical compound would not solely influence effective drug properties and reduce unnecessary side effects. Proteins/enzymes responsible for microbe proliferation or survival are specifically targeted and inhibited successfully making the cells to undergo apoptosis. Furthermore, isoforms of essential enzymes have distinct physiological functions; thereby inhibition of essential enzyme isoforms is an apt way to the clinical approach of disease neutralization. Drugs are designed so as to play significant roles such as signaling pathways in the oncogenic process including cell proliferation, invasion, and angiogenesis. The present review comprises collective information of the recent synthesis of various organic drug compounds in brief, which could inhibit particular enzyme. The review also covers the correlation of the structure of a drug molecule designed and its inhibitory activity. Also, the most significant enzyme inhibitors are highlighted and structural moieties/core units responsible for remarkable inhibitory values are emphasized. Elsevier 2020-04-02 /pmc/articles/PMC7132078/ /pubmed/32274429 http://dx.doi.org/10.1016/j.heliyon.2020.e03656 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Dorababu, Atukuri Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles |
title | Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles |
title_full | Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles |
title_fullStr | Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles |
title_full_unstemmed | Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles |
title_short | Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles |
title_sort | synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132078/ https://www.ncbi.nlm.nih.gov/pubmed/32274429 http://dx.doi.org/10.1016/j.heliyon.2020.e03656 |
work_keys_str_mv | AT dorababuatukuri synthesispharmacologicalevaluationandstructureactivityrelationshipofrecentlydiscoveredenzymeantagonistazoles |